T790M mutations identified by circulating tumor DNA test in lung adenocarcinoma patients who progressed on first-line epidermal growth factor receptor-tyrosine kinase inhibitors
Background: Plasma circulating tumor deoxyribonucleic acid (ctDNA) test is an alternative method to detect the T790M mutation. Compared to conventional tumor rebiopsy, ctDNA possesses several advantages including less invasive, faster, lower costs, and having minimal risk of complications for patien...
Saved in:
Main Authors: | Virodini Merinda, -, Gatot Soegiarto, -, Laksmi Wulandari, - |
---|---|
Format: | Article PeerReviewed |
Language: | English English English English English |
Published: |
Wolters Kluwer Medknow Publications
2019
|
Subjects: | |
Online Access: | https://repository.unair.ac.id/118318/1/Karil%20Artikel%209.pdf https://repository.unair.ac.id/118318/2/Artikel%209.pdf https://repository.unair.ac.id/118318/3/Turnitin%20Artikel%209.pdf https://repository.unair.ac.id/118318/6/1.%20Karil_3.pdf https://repository.unair.ac.id/118318/7/4.%20koresponden_3.pdf https://repository.unair.ac.id/118318/ https://journals.lww.com/lungindia/Fulltext/2020/37010/T790M_mutations_identified_by_circulating_tumor.4.aspx https://doi.org/ 10.4103/lungindia.lungindia_182_19 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Universitas Airlangga |
Language: | English English English English English |
Similar Items
-
Evaluation of Patients with Lung Cancer Treated with Epidermal Growth Factor Receptor–Tyrosine Kinase Inhibitor
by: Laksmi Wulandari, et al.
Published: (2018) -
Comparison of Detection of Epidermal Growth Factor Receptor (EFGR) Gene Mutation in Peripheral Blood Plasma (Liquid Biopsy) with Cytological Specimens in Lung Adenocarcinoma Patients
by: Laksmi Wulandari, -, et al.
Published: (2020) -
Case report: Management of Progressive Lung Cancer Patients after First-Line EGFR Tyrosine Kinase Inhibitor Therapy
by: Sahrun, -, et al.
Published: (2019) -
PROFIL MUTASI T790M PASIEN KANKER PARU ADENOKARSINOMA YANG
MENGALAMI PROGRESIVITAS SETELAH MENDAPATKAN INHIBITOR TIROSIN KINASE SEBAGAI TERAPI LINI PERTAMA DENGAN PEMERIKSAAN CIRCULATING TUMOR DNA
by: Vinodini Merinda, NIM011328096306
Published: (2018) -
Impact of smoking and brain metastasis on outcomes of advanced EGFR mutation lung adenocarcinoma patients treated with first line epidermal growth factor receptor tyrosine kinase inhibitors
by: Jain A., et al.
Published: (2020)